Wall Street has graduated from FAANG to the Magnificent 7, and now a new acronym is circulating among investors seeking the next major leg of the artificial intelligence trade.
The grouping is called MANGOS, standing for Meta Platforms (NASDAQ: META), Anthropic, NVIDIA (NASDAQ: NVDA), Google, OpenAI, and SpaceX, blending frontier AI developers with the dominant chip supplier powering them all.
Five of the six members are actively building frontier AI models, while NVIDIA provides the semiconductor infrastructure underpinning the entire industry’s expansion.
Investor Gavin Baker has suggested these six companies could be worth as much as $2 trillion combined if they were all publicly traded today, underscoring both the excitement and the speculative weight behind the label.
The MANGOS concept arrives alongside a broader investor rotation into themed stock cohorts, following recent buzz around the so-called Parabolic 7, which included names like Advanced Micro Devices (NASDAQ: AMD), Broadcom (NASDAQ: AVGO), and Intel (NASDAQ: INTC).
Of the six MANGOS members, only three currently trade on public markets, starting with Meta Platforms, which reported Q1 2026 revenue of $56.31 billion, up 33% year over year, with earnings per share of $10.44.
CEO Mark Zuckerberg told investors the company is “on track to deliver personal superintelligence to billions of people,” while full-year capital expenditure guidance was raised to a range of $125 billion to $145 billion.
Despite that momentum, Meta shares are down 13% year to date, with the stock’s trailing price-to-earnings ratio of 21x sitting well below the broader Magnificent 7 average, while prediction markets assign an 89% probability the stock closes above $520 at month-end.
NVIDIA delivered Q1 FY2027 revenue of $81.62 billion, up 85% year over year, with Data Center revenue alone reaching $75.25 billion, and CEO Jensen Huang characterizing the moment as “the largest infrastructure expansion in human history.”
The chipmaker’s board approved an additional $80 billion share buyback program, and NVDA shares have risen 9% year to date, reinforcing its central role within any AI-focused portfolio construction.
Alphabet (NASDAQ: GOOGL) rounds out the publicly traded MANGOS trio, reporting Q1 2026 revenue of $109.9 billion, up 22%, with Google Cloud growing 63% and the company’s backlog approaching $460 billion.
GOOGL has led the public MANGOS members with a 14% gain year to date, and some retail traders on Reddit have openly described it as “the only MAG7 worth owning.”
The remaining three MANGOS names are still private, though the IPO calendar is beginning to fill in, with SpaceX expected to list next week after its S-1 filing disclosed $4,694 million in Q1 2026 revenue and a 2025 Connectivity segment generating $7,168 million in Segment Adjusted EBITDA.
SpaceX also acquired xAI in February to form its AI segment, adding another dimension to an already complex corporate structure that investors will need to assess ahead of any listing.
OpenAI has reportedly filed confidentially for an IPO, and Anthropic is expected to come public later this year, with Amazon (NASDAQ: AMZN) CEO Andy Jassy noting Anthropic is securing up to 5 gigawatts of Trainium capacity.
Microsoft (NASDAQ: MSFT) holds the deepest relationship with OpenAI among publicly traded companies, and its AI business has surpassed a $37 billion annual revenue run rate, representing 123% growth year over year.
The broader SPDR S&P 500 ETF (NYSE ARCA: SPY) is up 7% year to date, but dispersion within the AI cohort is significant enough that stock selection within the theme carries real consequence.
The MANGOS framework captures a genuine structural shift as the AI build-out expands beyond the original Magnificent 7 and approaching mega-IPOs could reshape index weightings in ways not seen since the late-1990s tech listings.
Treating MANGOS as a research framework rather than a ready-made shopping list may serve investors better, particularly as IPO timing and valuations remain subject to rapid change in the current market environment.
